Skip to content

Clinical trials

Phase 2 Adenocarcinoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Phase 2 Country / region: France Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20083
20093
20102
20112
20143
20152
20161
20181
20211
20221
20233
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated6
Active, not recruiting4
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
UNICANCER6
Assistance Publique - Hôpitaux de Paris2
Centre Oscar Lambret2
Novartis Pharmaceuticals2
Boston Scientific Corporation1
Bristol-Myers Squibb1
Clovis Oncology, Inc.1
EMD Serono Research & Development Institute, Inc.1
ERYtech Pharma1
Elevation Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma25
Neoplasms7
Carcinoma5
Colorectal Neoplasms5
Neoplasm Metastasis5
Carcinoma, Non-Small-Cell Lung4
Digestive System Neoplasms3
Neoplasms by Histologic Type3
Neoplasms by Site3
Neoplasms, Glandular and Epithelial3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.